L R Prosnitz
Overview
Explore the profile of L R Prosnitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorth J, Chino J, Prosnitz L, Diehl L, Beaven A, Coleman R, et al.
Ann Oncol
. 2010 Aug;
22(2):405-10.
PMID: 20675560
Background: 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography (PET) and gallium-67 citrate (gallium) response after chemotherapy are powerful prognostic factors in diffuse large B-cell lymphoma (DLBCL). However, clinical outcomes when consolidation radiation therapy (RT)...
2.
Anscher M, Clough R, Robertson C, Prosnitz L, Dahm P, Walther P, et al.
Prostate Cancer Prostatic Dis
. 2006 Aug;
9(3):254-60.
PMID: 16880828
To determine the timing and patterns of late recurrence after radical prostatectomy (RP) alone or RP plus adjuvant radiotherapy (RT). Between 1970 and 1983, 159 patients underwent RP for newly...
3.
Hahn C, Jones E, Blivin J, Sanders L, Yu D, Dewhirst M, et al.
Int J Hyperthermia
. 2005 Jul;
21(4):349-57.
PMID: 16019860
Purpose: Prospective assessment of quality of life (QoL) in patients with refractory, residual or recurrent ovarian cancer receiving whole abdomen hyperthermia and intravenous liposomal doxorubicin chemotherapy. Methods: Treatment consisted of...
4.
Alvarez Secord A, Jones E, Hahn C, Petros W, Yu D, Havrilesky L, et al.
Int J Hyperthermia
. 2005 Jul;
21(4):333-47.
PMID: 16019859
Objective: A phase I/II study of Doxil combined with whole abdomen hyperthermia was conducted in patients with refractory ovarian cancer. Liposomal doxorubicin combined with hyperthermia has been shown to increase...
5.
Vujaskovic Z, Rosen E, Blackwell K, Jones E, Brizel D, Prosnitz L, et al.
Int J Hyperthermia
. 2003 Aug;
19(5):498-506.
PMID: 12944165
The objective of this study was to determine whether neoadjuvant chemotherapy in combination with hyperthermia (HT) would improve oxygenation in locally advanced breast tumours. The study describes a new optimized...
6.
Maguire P, Samulski T, Prosnitz L, Jones E, Rosner G, Powers B, et al.
Int J Hyperthermia
. 2001 Jul;
17(4):283-90.
PMID: 11471980
We prospectively evaluated whether delivering a thermal dose of > 10 cumulative equivalent minutes at 43 degrees C to >90% of the tumour sites monitored (CEM43 degrees T90) would produce...
7.
Marks L, Bentel G, Hardenbergh P, Lind P, Prosnitz L
Int J Radiat Oncol Biol Phys
. 2001 May;
50(2):421-5.
PMID: 11380229
Purpose: To assess the distance from a clinically recognized anatomic landmark to the different costocondral interspaces in female patients to facilitate the design of radiation fields intended to include specific...
8.
Hardenbergh P, Munley M, Bentel G, Kedem R, Borges-Neto S, Hollis D, et al.
Int J Radiat Oncol Biol Phys
. 2001 Mar;
49(4):1023-8.
PMID: 11240243
Purpose: To determine the incidence and dose dependence of regional cardiac perfusion abnormalities in patients with left-sided breast cancer treated with radiation therapy (RT) with and without doxorubicin (Dox). Methods:...
9.
10.
Elconin J, Roberts K, Rizzieri D, Vermont C, Clough R, Kim C, et al.
Int J Radiat Oncol Biol Phys
. 2000 Nov;
48(4):1097-105.
PMID: 11072168
Purpose: To determine the effective dose of consolidation radiation in Hodgkin's disease (HD) patients with large mediastinal adenopathy (LMA) treated with combined modality therapy (CMT). Methods And Materials: Eighty-three HD...